Skip to main content
. 2021 Sep 21;187(4):2865–2876. doi: 10.1093/plphys/kiab443

Table 1.

Summary of systemic infectivity of CMV in maize

CMVa
Infection efficiencyb
RNA1 RNA2 RNA3 14 dpi 28 dpi
Z1Z2Z3 Z Z Z 43.8% (7/16) 50.0% (8/16)
Z1F2Z3 Z F Z 13.3% (2/15) 26.7% (4/15)
Z1Z2F3 Z Z F 20.0% (3/15) 86.7% (13/15)
Z1F2F3 Z F F 80.0% (12/15) 93.3% (14/15)
F1F2F3 F F F 93.8% (15/16) 100.0% (16/16)
F1Z2F3 F Z F 100.0% (16/16) 100.0% (16/16)
F1F2Z3 F F Z 81.3% (13/16) 87.5% (14/16)
F1Z2Z3 F Z Z 68.8% (11/16) 93.8% (15/16)
F1Z2FZ3 F Z FZ 86.7% (13/15) 93.3% (14/15)
F1Z2ZF3 F Z ZF 60.0% (9/15) 93.3% (14/15)

aF, viral RNA from CMV-Fny; Z, viral RNA from the CMV-ZMBJ; FZ, chimeric viral RNA with 5′UTR and MP gene from Fny-RNA3 and CP gene and 3′-UTR from ZMBJ-RNA3; and ZF, chimeric viral RNA with 5′-UTR and MP gene from ZMBJ-RNA3 and CP gene and 3′-UTR from Fny-RNA3.

bAll of the inoculated plants were analyzed by western blotting from three independent experiments. The number of plants infected/the number of plants inoculated is indicated in the parenthesis.